Diabetes Research and Clinical Practice
Volume 74, Supplement 2 , Pages S77-S81, December 2006

Ketone bodies monitoring

  • Marco Orsini Federici

      Affiliations

    • Corresponding Author InformationCorresponding author. Address for correspondence: Marco Orsini Federici, MD, PhD, Department of Internal Medicine, University of Perugia, Via E. Dal Pozzo, 1–06126 Perugia, Italy. Tel./Fax: +39 075 5727627
  • ,
  • Massimo Massi Benedetti

Department of Internal Medicine, University of Perugia, Perugia, Italy

Abstract 

Diabetic ketoacidosis (DK) is a serious acute complication in type 1 diabetic patients caused by insulin deficiency. The early detection of insulin deprivation represents therefore an important element in routine clinical practice, especially in ketone prone subjects such as CSII (continuous subcutaneous insulin infusion) treated subjects. Different methods have been developed for ketone bodies (KB) monitoring: urine dipsticks, laboratory readings, capillary β-hydroxybutirate (BOHB) meters. Urine dipsticks are not recommended for KB monitoring because they measure only acetoacetate and not BOBH the most prevalent ketone during DK. Laboratory methods are more reliable but not useful for self monitoring. Capillary BOHB represents the most suitable method for KB monitoring in home settings. Several experiences demonstrated the accuracy and reliability of this method at different degree of ketosis and their efficacy in detecting and managing the course of DKA. A recent experience, conducted by our group, investigated the efficacy of the dynamic evaluation of capillary BOBH levels, irrespectively of the absolute value, for early detection of insulin deprivation in CSII treated subjects. Results indicated that dynamic evaluation of capillary BOHB appears as a more rapid and accurate indicator of early insulin deprivation than blood glucose and could be used for targeting effectively insulin therapy in the restoration phase.

Keywords:  Continuous subcutaneous insulin infusion , Kctone bodies , 3-betahydroxybutirate , Ketoacidosis , Type 1 diabetes mellitus

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(06)70004-3

doi:10.1016/S0168-8227(06)70004-3

Diabetes Research and Clinical Practice
Volume 74, Supplement 2 , Pages S77-S81, December 2006